Stay updated on Zilucoplan in PNH Patients Clinical Trial
Sign up to get notified when there's something new on the Zilucoplan in PNH Patients Clinical Trial page.

Latest updates to the Zilucoplan in PNH Patients Clinical Trial page
- ChecktodayChange DetectedThe Phase 2 zilucoplan study record for patients with paroxysmal nocturnal hemoglobinuria is available, with trial design, treatment arms, eligibility criteria, outcomes, locations, and study documents.SummaryDifference49%

- Check7 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error rather than study details.SummaryDifference0.2%

- Check14 days agoChange DetectedA notice about NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” appears above the blocked study record page.SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the study page remains a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer’s displayed site revision advances from v3.7.0 to v3.7.1; the page remains a 403 error.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now shows a 403 Forbidden error screen with minimal navigation, replacing the previously accessible study-record content.SummaryDifference17%

Stay in the know with updates to Zilucoplan in PNH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zilucoplan in PNH Patients Clinical Trial page.